FGF19 and hepatocellular carcinoma: On the other hand, the FGF19–GFR4–KLB signaling pathway is recognized as a major driver of disease initiation and progression, being involved in the regulation of cell proliferation, survival, EMT, migration, and invasion in HCC cells [132,140,141,142,143,144,145,146,147].